Robert Dziura

BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma

Bożena Cybulska-Stopa, Paweł Rogala, Anna M. Czarnecka et al. · Melanoma Research · 2020 · 21 citations

Medicine, Oncology, Pharmacotherapy +15

Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment

Bożena Cybulska-Stopa, Karolina Piejko, Krzysztof Ostaszewski et al. · Melanoma Research · 2023 · 14 citations

Medicine, Oncology, Pharmacotherapy +16

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report

Joanna Placzke, Magdalena Rosińska, Paweł Sobczuk et al. · Cancers · 2023 · 13 citations · Full text

Medicine, Clinical Sciences, Oncology +17

High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors

Paweł Teterycz, Paulina Jagodzińska-Mucha, Bożena Cybulska-Stopa et al. · Melanoma Research · 2018 · 12 citations

Medicine, Hematology, Oncology +17

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients

Paweł Rogala, Anna M. Czarnecka, Bożena Cybulska-Stopa et al. · Cancers · 2022 · 10 citations · Full text

Medicine, Oncology, Pharmacology +17